Martin Shkreli

On Wednesday, former hedge fund manager known as the "Pharma Bro," Martin Shkreli, pushed back on Sen. Elizabeth Warren's (D-Mass.) accusations that several major U.S. corporations paid no federal income tax. Warren Targets Major US Corporations Warren took to X and said that if taxpayers paid even...

Strategy Inc. (NASDAQ:MSTR) saw its stock price slide before heading back up during Tuesday's trading session. • What is MSTR stock doing now? Bitcoin Remains Relatively Flat Strategy shares seesawing comes as Bitcoin (CRYPTO: BTC) shows minimal volatility. The leading digital asset is...

Investor Martin Shkreli, popularly known as "Pharma Bro," slammed Michael Saylor’s latest video on Monday promoting Strategy Inc.‘s (NASDAQ: MSTR) preferred stock offering. The Video At The Center Of Controversy The AI video shared on X showed a young woman who has retired and is living a...

Martin Shkreli and U.S. Rep. Alexandria Ocasio-Cortez are unexpectedly aligned in arguing that Kalshi hasn't gone far enough in policing who can trade on its event markets. DKNG stock is moving. See the chart and price action here.  Shkreli and AOC's Rare Agreement In a social media post,...

Investor Martin Shkreli, popularly referred to as the “Pharma Bro,” released the traffic data of leading AI websites while highlighting the stark disparities in the usage of popular chatbots. ChatGPT, Gemini Lead The Charge On Tuesday, in a post on X, Shkreli said, “55 billion...

Investor Martin Shkreli’s big biotech short position is blowing up after the stock’s monumental rally over the past week, following a major clinical catalyst. Popularly known as “Pharma bro,” Shkreli initiated a short position against California-based Capricor Therapeutics...

Capricor Therapeutics, Inc. (NASDAQ:CAPR) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate, deramiocel.  CAPR stock is soaring. See the real-time price action here.  The data release and stock...

While comparing U.S. equity market returns over the past 35 years with those of France and Japan, investor Martin Shkreli issued a sharp warning regarding the growing influence of progressive lawmakers on the nation’s economy. Our Markets Will ‘Look Like Theirs’ On Tuesday, in a...

Shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR) plummeted Monday due to a short call from controversial former pharmaceutical executive Martin Shkreli. CAPR stock is plunging. See the real-time price action here.  "HOPE-3, aka COPE-3" Shkreli publicly identified Capricor as a short...

Martin Shkreli, the former hedge fund manager known as the "Pharma Bro," scolded online finance personalities Thursday after they hunted for alleged red flags in Nvidia Corp.'s (NASDAQ:NVDA) third-quarter financial statements, saying many don't grasp basic accounting. Shkreli Slams Influencers Over...

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) soared Tuesday in reaction to Roche Holdings AG‘s (OTC:RHHBY) phase 3 results from the lidERA Breast Cancer study of giredestrant in early-stage breast cancer. "Pharma Bro” and notorious bear Martin Shkreli is shorting Olema stock....

Martin Shkreli, notorious for his market commentary and controversial strategies, has been aggressively shorting quantum computing stocks. And it looks like his bearish bets are paying off.  RGTI stock is up today. See the real-time price action here.  Shkreli placed short bets against...

Plant-based meat company Beyond Meat Inc (NASDAQ:BYND) is set to report third-quarter financial results Monday after market close. The report comes after the company delayed its earnings report, originally planned for last week. Here are the earnings estimates and key items to watch. Earnings...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock fell sharply Tuesday following disappointing results from a key clinical trial and ongoing concerns about its drug pipeline. However, "Pharma Bro" Martin Shkreli said he still likes the stock.  SRPT stock is crashing. See the real-time price...

Gov. Ron DeSantis (R) expressed concerns regarding OpenAI’s critical importance to the economy and the broader tech ecosystem. Not ‘Too Big To Fail’ On Sunday, in a post on X, DeSantis signaled his unease, citing a Wall Street Journal piece that asked if the AI giant was becoming...